Brief: Akoya Biosciences Says Revenue For Q4 2023 Is Expected To Be Between $25.5 Mln-$26.5 Mln

Akoya Biosciences

07/01/2024 13:03

Jan 7 (Reuters) - Akoya Biosciences Inc  AKYA.O :
    * AKOYA BIOSCIENCES ANNOUNCES PRELIMINARY FINANCIAL RESULTS
FOR
THE FOURTH QUARTER AND FULL YEAR 2023 AND PROVIDES 2024 OUTLOOK
    * REVENUE FOR Q4 OF 2023 IS EXPECTED TO BE BETWEEN $25.5
MILLION
AND $26.5 MILLION
    * FOR FISCAL YEAR OF 2023, REVENUE IS EXPECTED TO BE BETWEEN
$95.6
MILLION AND $96.6 MILLION
    * YEAR END 2023 PROJECTED CASH, CASH EQUIVALENTS, AND
RESTRICTED
CASH BALANCE IS EXPECTED TO BE BETWEEN $83.0 MILLION AND $85.0
MILLION
    * BASED ON ITS CURRENT PLANS AND INITIATIVES, EXPECTS FULL
YEAR
2024 REVENUE TO GROW 20%+
    * BASED ON ITS CURRENT PLANS AND INITIATIVES, PROJECTS
ACHIEVING
OPERATING CASH FLOW BREAKEVEN BY YEAR END 2024

Source text for Eikon:  ID:nGNX2kxq0m 
Further company coverage:  AKYA.O 

 ((Reuters.Briefs@thomsonreuters.com;))